Moleculin Biotech, Inc. Quarterly Current Ratio in % from Q1 2017 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Moleculin Biotech, Inc. quarterly Current Ratio history and growth rate from Q1 2017 to Q3 2024.
  • Moleculin Biotech, Inc. Current Ratio for the quarter ending September 30, 2024 was 299 %, a 58.9% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 299 -429 -58.9% Sep 30, 2024
Q2 2024 396 -367 -48.1% Jun 30, 2024
Q1 2024 477 -427 -47.2% Mar 31, 2024
Q4 2023 577 -464 -44.6% Dec 31, 2023
Q3 2023 729 -503 -40.8% Sep 30, 2023
Q2 2023 763 -785 -50.7% Jun 30, 2023
Q1 2023 905 -1.03K -53.2% Mar 31, 2023
Q4 2022 1.04K -1.06K -50.5% Dec 31, 2022
Q3 2022 1.23K -590 -32.4% Sep 30, 2022
Q2 2022 1.55K +132 +9.3% Jun 30, 2022
Q1 2022 1.93K +976 +102% Mar 31, 2022
Q4 2021 2.1K +1.61K +324% Dec 31, 2021
Q3 2021 1.82K +1.38K +309% Sep 30, 2021
Q2 2021 1.42K +1.11K +368% Jun 30, 2021
Q1 2021 955 +715 +298% Mar 31, 2021
Q4 2020 495 +293 +146% Dec 31, 2020
Q3 2020 445 +264 +145% Sep 30, 2020
Q2 2020 303 +98.2 +48% Jun 30, 2020
Q1 2020 240 +13.2 +5.82% Mar 31, 2020
Q4 2019 201 -139 -40.8% Dec 31, 2019
Q3 2019 182 -212 -53.8% Sep 30, 2019
Q2 2019 205 -241 -54.1% Jun 30, 2019
Q1 2019 227 -315 -58.1% Mar 31, 2019
Q4 2018 340 -118 -25.7% Dec 31, 2018
Q3 2018 393 -76.9 -16.3% Sep 30, 2018
Q2 2018 446 -18 -3.88% Jun 30, 2018
Q1 2018 542 +86.8 +19.1% Mar 31, 2018
Q4 2017 458 Dec 31, 2017
Q3 2017 470 Sep 30, 2017
Q2 2017 464 Jun 30, 2017
Q1 2017 455 Mar 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.